• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ther Adv Infect Dis . Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

tetano

Editor, Senior Moderator
Ther Adv Infect Dis


. 2023 Oct 20:10:20499361231207178.
doi: 10.1177/20499361231207178. eCollection 2023 Jan-Dec. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

Mateusz Bartoszewicz[SUP] 1 [/SUP], Sławomir Lech Czaban[SUP] 2 [/SUP], Klaudia Bartoszewicz[SUP] 3 [/SUP], Damian Kuźmiuk[SUP] 2 [/SUP], Jerzy Robert Ładny[SUP] 4 [/SUP]



Affiliations
Abstract

Background: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear.
Objective: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19.
Design: This was a single-center, retrospective cohort study.
Methods: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19. Logistic regression analysis was conducted to identify factors associated with BSI occurrence. Furthermore, we identified the primary causative pathogens of BSIs. The study outcomes were death or ICU discharge.
Results: Among the 201 included patients, 43 (21.4%) patients developed BSI. The mortality rate was non-significantly higher in the BSI group than in the BSI group (65.1% versus 58.9%, p = 0.487). There were significant between-group differences in the obesity prevalence and sex distribution, but not corticosteroid usage. BSI occurrence was significantly associated with duration of mechanical ventilation (MV), presence of ventilator-associated pneumonia, use of neuromuscular blocking agents, length of stay in ICU (ICU LOS), high body mass index (BMI), and male sex. The main causative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Enterococcus faecalis. Multi-drug-resistant pathogens were found in 87% of cases. Regardless of the origin, the common risk factors for BSI were ICU LOS and MV duration. All BSIs were acquired within the hospital setting, with ≈60% of the cases being primary BSIs. A small proportion of the BSI cases were catheter-related (four cases, 6.2%). Ventilator-associated pneumonia and urinary tract infections were present in 25% and 9.4% of the BSI cases, respectively. On average, the first positive blood culture appeared ≈11.4 (±9.7) days after ICU admission.
Conclusion: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs.

Keywords: COVID-19; bloodstream infections; intensive care unit.

 
Back
Top Bottom